Why is Aarti Drugs Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -8.96% of over the last 5 years
2
Flat results in Mar 26
- NO KEY NEGATIVE TRIGGERS
3
Stock is technically in a Mildly Bearish range
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -16.82% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Aarti Drugs for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Aarti Drugs
-16.82%
-0.47
36.03%
Sensex
-4.95%
-0.37
13.26%
Quality key factors
Factor
Value
Sales Growth (5y)
3.55%
EBIT Growth (5y)
-8.96%
EBIT to Interest (avg)
8.53
Debt to EBITDA (avg)
1.84
Net Debt to Equity (avg)
0.37
Sales to Capital Employed (avg)
1.40
Tax Ratio
7.57%
Dividend Payout Ratio
5.43%
Pledged Shares
2.47%
Institutional Holding
11.80%
ROCE (avg)
14.70%
ROE (avg)
14.40%
Valuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
34
Price to Book Value
2.17
EV to EBIT
16.25
EV to EBITDA
12.73
EV to Capital Employed
1.86
EV to Sales
1.53
PEG Ratio
1.03
Dividend Yield
0.55%
ROCE (Latest)
11.44%
ROE (Latest)
12.58%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Movement
7What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 11.74 times
NET SALES(Q)
Highest at Rs 720.30 cr
PBDIT(Q)
Highest at Rs 95.80 cr.
PBT LESS OI(Q)
Highest at Rs 69.60 cr.
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Aarti Drugs
Operating Profit to Interest - Quarterly
Highest at 11.74 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales - Quarterly
Highest at Rs 720.30 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 95.80 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 69.60 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 69.60 cr has Grown at 33.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 52.05 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)